Vote!
Combined use of recommended heart failure therapies significantly boosts survival odds
This study provides patients, clinicians, purchasers and policymakers with compelling evidence of the incremental improvements in clinical outcomes for patients with heart failure that can be achieved with guideline-recommended therapies." Each individual therapy, with a single exception, was also associated with a survival benefit. Beta blockers and cardiac resynchronization therapy imparted the greatest individual benefits by providing lowered odds of mortality of 42 percent and 44 percent, respectively. Fonarow also noted that being able to independently value these heart failure therapies may provide a basis for choosing between...
Published By: MedWorm/RelationshipIssues - Wednesday, 22 February
